Google Is Changing How Cookies Work. What Does This Mean for Sponsors and CROs?
Google recently announced it will phase out third-party cookies. How will this impact sponsors and CROS looking to recruit patients for clinical trials?
How Will the First “Right To Try” CRO Impact Clinical Trials?
The launch of the first Right to Try CRO, Beacon of Hope, could mean easier access to life-saving treatments for terminally ill patients – and reduced costs for drug developers.
Have the Benefits of CBD and Medical Marijuana Been Proven in Clinical Trials?
Medical cannabis is getting a great deal of press as a treatment for a variety of medical conditions, but what kind of evidence have we seen for these claims?
Swipe Right to Enroll in a Clinical Trial: Are Patient Recruitment Apps the Future or a Fad?
Mobile apps may provide some benefits to patients looking for clinical trials, but digital marketing remains the gold standard of patient recruitment.
Big Tech’s Growing Interest in Clinical Trial Marketing
Alphabet’s Verily is partnering with major pharma companies, marking an industry-wide shift toward patient-centric trial design and strategic digital patient recruitment.
How Showing Appreciation for Past Clinical Trial Patients Can Help to Recruit New Ones
A recent initiative undertaken by pharmaceutical company Eli Lilly shows the importance of saying, “Thank You,” to clinical trial patients.
Many Clinical Trials Go Unpublished. Here’s How Digital Marketing Can Help.
Many clinical trials struggle with recruitment and publishing delays, but digital marketing initiatives can help sponsors and CROs meet important deadlines.
Study Shows Patients Are Open to Clinical Trials, But Can’t Find Them
In a recent study, 73% of people who had not participated in a clinical trial reported they would be open to doing so. Now it’s up to sponsors and CROs to engage this untapped audience.
Use Digital Marketing to Combat Patient Fears about Placebos in Clinical Trials
As it turns out, placebos in clinical trials are much less common than people think. So how can CROs and sponsors reassure patients that they will receive treatment?
